ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,220,405, issued on Feb. 11.
"Compositions for the treatment of hepatic steatosis" was invented by Thomas Winston (Stillwell, Kan.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are pharmaceutical compositions to treat, prevent, reduce the incidence of, or reduce the severity of hepatic steatosis comprising an effective amount of one or more mTOR inhibitors and optionally an effective amount of one or more thyroid hormones. Further disclosed herein are methods of treating, preventing, reducing the incidence of, or reducing the severity of hepatic steatosis comprising administering an effective amount of a pharmaceutical composition of on...